Back to 
CITADEL ADVISORS LLC
CITADEL ADVISORS LLC
XLO1 quarters
Position history for CITADEL ADVISORS LLC's holdings in XILIO THERAPEUTICS INC
CITADEL ADVISORS LLC holds 25,950 shares of XLO (XILIO THERAPEUTICS INC), worth $248,601 as of 2026-Q2. This is a new position.
Current Value
$248,601
Current Shares
25,950
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of XLO: VANGUARD CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY